Fora Care to Launch New Hematocrit level measuring Blood Glucose Monitor and Bluetooth-enabled BP monitor for iOS and Android Platforms at European Association for the Study of Diabetes (EASD) in Barcelona at Booth #F.06

ST. GALLEN, Switzerland, September 13, 2013 /PRNewswire/ --

Fora Care Suisse AG located in St. Gallen, Switzerland, announced today it will be exhibiting at the European Association for the Study of Diabetes (EASD) meeting September 23-27, 2013 in the Barcelona, Spain at The Fira de Barcelona's Gran Via exhibition to showcase the latest in professional diabetes measurement and consumer BP monitoring technology. Fora Care's booth is #F.06.

Fora Care will present its FORA COMFORT pro GD40 blood glucose-monitoring device, with 5-Electrode Technology, offering the highest clinical accuracy and system performance available.  Glucose results can be falsely high or falsely low, depending on the hematocrit level, potentially leading to incorrect insulin dosage or even an incorrect diagnosis. Since variations in hematocrit are a major source of errors in blood glucose measurement, Fora Care's 5-Electrode Technology measures hematocrit level and offsets the impact on measurement and meets the New guidelines for monitoring impact from hematocrit levels added to the new ISO 15197:2013.

The FORA COMFORT pro GD40 is recommended for hospital/clinic settings, neonatal care, gestational diabetes care or treatments, and other settings that require tight glycemic control.

Fora Care will demonstrate its newest blood pressure (BP) monitor, FORA Diamond Cuff BP, that provides simple and convenient upload of BP readings, via Bluetooth, to iFORA BP, a free mobile app available on iOS (including iPhone®) and Android® platforms. This newest offering is an extension to the Total and Complete Mobility solution.

iFORA BP tracks systolic and diastolic blood pressure and pulse rate and provides weekly and monthly graphical trends that can be exported or shared with family or physicians with data that may also be exported.   The app allows the user to apply personal notes to each result and provides a tutorial with tips to help users better manage their blood pressure for better health.

"Fora Care Suisse AG is honored to present to the European market in Barcelona showcasing our new technologies to our customers," said Ty-Minh Tan, CEO of Fora Care Suisse AG.  "We invite physicians and researchers to visit our booth to discuss the possibilities of clinical application studies."

All Fora Care monitoring devices are validated as highly accurate in the industry and provide superior quality directly to consumers.  FORA Blood Glucose Monitors are validated according to ISO 15197 requirements at an internationally renowned diabetes institute in Ulm, Germany.

Fora Care devices comply with new ISO standards and have completed third party validations:

• FORA Diamond strips (for the Diamond series) is clinically validated in Czech and Switzerland and is proven to meet the +/- 15% required by the new ISO 15197:2013.
• FORA Comfort pro GD40 (with 5-electrode technology) is clinically validated in Switzerland and is proven to meet the +/- 15% required by the new ISO 15197:2013

Fora Care provides FDA cleared and CE marked innovative health monitoring devices that provide simple connection to the FORA system. For more information, please visit

About ForaCare Suisse AG: http://www.foracare.ch/

Contact:

Elena Birrer
+41-71-220-1001

SOURCE ForaCare Suisse AG